Literature DB >> 6298607

Plasmid-directed synthesis of hepatitis B surface antigen in monkey cells.

C W Crowley, C C Liu, A D Levinson.   

Abstract

We introduced the gene encoding the hepatitis B virus surface antigen (HBsAg) into simian virus 40 (SV40)-based plasmids capable of autonomously replicating in both Escherichia coli and permissive monkey cells. After introduction into monkey cells by transfection, these plasmids directed the synthesis of high levels of HBsAg, as determined by immunofluorescence, radioimmunoassays, and identification by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the polypeptides comprising the antigen. Expression was dependent upon the presence of an SV40 promoter, with both the early and late promoters able to effectively initiate transcription. Using expression of HBsAg to assay promoter function, we demonstrated that an intact copy of the SV40 72-base pair repeat, which constitutes an essential element of the SV40 early promoter during the lytic SV40 cycle and which can enhance the transcriptional activity of heterologous promoters, was not required for HBsAg expression, suggesting that the hepatitis genome contains an enhancer element capable of complementing that provided by the 72-base pair repeat element of SV40. The antigen appears to be glycosylated after synthesis in transfected cells and is apparently secreted, as evidenced by the localization of [35S]cysteine-labeled antigen to the medium of transfected cultures. Using constructions in which the first ATG sequence appearing in HBsAg mRNA was that corresponding to the gene encoding the mature form of the antigen, we demonstrated that these post-translational events could occur without the involvement of a putative precursor peptide suggested by the DNA sequence of the viral genome. In view of the inability of hepatitis B virus to propagate in vitro, this strategy offers a convenient approach for further characterizing the biosynthesis of this antigen and may provide a means to identify additional polypeptides encoded by this virus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6298607      PMCID: PMC368501          DOI: 10.1128/mcb.3.1.44-55.1983

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Restriction endonucleases, simian virus 40, and the new genetics.

Authors:  D Nathans
Journal:  Science       Date:  1979-11-23       Impact factor: 47.728

2.  Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.

Authors:  J Favaloro; R Treisman; R Kamen
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

Review 3.  Transcription and RNA processing by the DNA tumour viruses.

Authors:  E B Ziff
Journal:  Nature       Date:  1980-10-09       Impact factor: 49.962

4.  Expression of early genes of origin-defective mutants of simian virus 40.

Authors:  Y Gluzman; J F Sambrook; R J Frisque
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

5.  Recovery of DNA from gels.

Authors:  H O Smith
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Polypeptides of hepatitis B virus surface antigen produced by a hepatoma cell line.

Authors:  P L Marion; F H Salazar; J J Alexander; W S Robinson
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

7.  Hepatitis B virus genes and their expression in E. coli.

Authors:  M Pasek; T Goto; W Gilbert; B Zink; H Schaller; P MacKay; G Leadbetter; K Murray
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

8.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

9.  Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA.

Authors:  M F Dubois; C Pourcel; S Rousset; C Chany; P Tiollais
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

10.  Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; W R Oleszko; D C William; R Sadovsky; J M Morrison; A Kellner
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

View more
  24 in total

1.  Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformation.

Authors:  S Massoglia; A Gray; T J Dull; S Munemitsu; H J Kun; J Schlessinger; A Ullrich
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

2.  Comparison of intron-dependent and intron-independent gene expression.

Authors:  A R Buchman; P Berg
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

3.  Ligand activation of overexpressed epidermal growth factor receptors transforms NIH 3T3 mouse fibroblasts.

Authors:  H Riedel; S Massoglia; J Schlessinger; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

4.  Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences.

Authors:  A McLachlan; D R Milich; A K Raney; M G Riggs; J L Hughes; J Sorge; F V Chisari
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

5.  Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity.

Authors:  J L Vannice; A D Levinson
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

6.  Epidermal growth factor (EGF) modulation of feline sarcoma virus fms tyrosine kinase activity, internalization, degradation, and transforming potential in an EGF receptor/v-fms chimera.

Authors:  H Riedel
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

7.  Transcription of hepatitis B virus by RNA polymerase II.

Authors:  L B Rall; D N Standring; O Laub; W J Rutter
Journal:  Mol Cell Biol       Date:  1983-10       Impact factor: 4.272

8.  Isolation and expression of an altered mouse dihydrofolate reductase cDNA.

Authors:  C C Simonsen; A D Levinson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

9.  Expression of hepatitis B antigens with a simian virus 40 vector.

Authors:  H Will; R Cattaneo; E Pfaff; C Kuhn; M Roggendorf; H Schaller
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

10.  Hepatitis B virus encodes an RNA polymerase III transcript.

Authors:  D N Standring; L B Rall; O Laub; W J Rutter
Journal:  Mol Cell Biol       Date:  1983-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.